Dopamine D4 receptors elevated in schizophrenia

Nature

Volumn 365, Issue 6445, 1993, Pages 441-445

  Seeman, Philip ^a   Guan, Hong Chang ^a   Van Tol, Hubert H M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR;

ARTICLE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SCHIZOPHRENIA;

AGED; AGED, 80 AND OVER; CORPUS STRIATUM; DOPAMINE; FEMALE; GUANINE NUCLEOTIDES; HUMAN; MALE; MIDDLE AGE; RACLOPRIDE; RECEPTORS, DOPAMINE; SALICYLAMIDES; SCHIZOPHRENIA; SUPPORT, NON-U.S. GOV'T;

EID: 0027485692     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/365441a0     Document Type: Article

References (32)

1. Carter, G. I., Taylor, G. R. & Crow, T. J. J. Neurol. Neurosurg. Psychiat. 50, 247–251 (1987).
2. Spokes, E.G.S., Garrett, N. J., Rossor, M. N. & Iversen, L. L. J. neurolog. Sci. 48, 303–313 (1980).
3. Andreasen, N. C. Science 239, 1381–1388 (1988).
4. Suddath, R. L., Christison, G.W., Torrey, E.F., Casanova, M. F. & Weinberger, D. R. New Engl. J. Med. 322, 789–794 (1990).
5. Buchsbaum, M. S. et al. Arch. gen. Psychiat. 49, 935–942 (1992).
6. Crow, T. J. et al. in Enzymes and Neurotransmitters in Mental Disease (eds Usdin, E., Sourkes, T. L. & Youdim, M. B. H.) 559–572 (Wiley, New York, 1980).
7. Meitzer, H. Y. Schizophrenia Bull. 17, 263–287 (1991).
8. Lee, T., Seeman, P., Tourtellotte, W. W., Farley, I. J. & Hornykiewicz, O. Nature 274, 897–900 (1978).
9. Seeman, P., Niznik, H. B., Guan, H.-C., Booth, G. & Ulpian, C. Proc. natn. Acad. Sci. U.S.A. 86, 10156–10160 (1989).
10. Seeman, P., Wong, M. & Lee, T. Fedn Proc. 33, 246 (1974).
11. Seeman, P., Chau-Wong, M., Tedesco, J. & Wong, K. Proc. natn. Acad. Sci. U.S.A. 72, 4376–4380 (1975).
12. Seeman, P. et al. Neuropsychopharmacology 1, 5–15 (1987).
13. Seeman, P. Neuropsychopharmacology 7, 261–284 (1992).
14. Wong, D.F. et al. Science 234, 1558–1563 (1986).
15. Farde, L. et al. Arch. gen. Psychiatry 47, 213–219 (1990).
16. Van Tol, H. H.M. et al. Nature 350, 610–614 (1991).
17. Lichter, J. B., Livak, K. J., Rogers, J., Kennedy, J. L. & Van Tol, H. H. M. Nature 360, 424 (1992).
18. Seeman, P., Guan, H.-C., Van Tol, H. H. M. & Niznik, H. B. Synapse 14, 247–253 (1993).
19. Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L. & Schwartz, J.-C. Nature 347, 146–151 (1990).
20. Seeman, P., Guan, H.-C. & Niznik, H. B. Synapse 3, 96–97 (1989).
21. Seeman, P., Ulpian, C., Wreggett, K. A. & Wells, J. J. Neurochem. 43, 221–235 (1984).
22. Lazareno, S. J. Receptor Res. 3, 163–175 (1983).
23. George, S. R., Watanabe, M. & Seeman, P. J. Neurochem. 44, 1168–1177 (1985).
24. Seeman, P. & Niznik, H. B. ISI Atlas Sci. Pharmac. 2, 161–170 (1988).
25. Seeman, P. & Schaus, J. M. Eur. J. Pharmac. 203, 105–109 (1991).
26. Battaglia, G., Shannon, M. & Titeler, M. J. Neurochem. 43, 1213–1219 (1984).
27. Ezrin-Waters, C., Seeman, M. V. & Seeman, P. J. din. Psychiat. 42, 16–22 (1981).
28. Seeman, P. et al. Eur. J. Pharmac. molec. Pharmac. Sect. 227, 139–146 (1992).
29. Wreggett, K. A. & Seeman, P. Molec. Pharmac. 25, 10–17 (1984).
30. Seeman, P., Ulpian, C., Grigoriadis, D., Pri-Bar, I. & Buchman, O. Biochem. Pharmac. 34, 151–154 (1985).
31. Van Tol, H. H.M. et al. Nature 358, 149–152 (1992).
32. Hall, H., Haiidin, C. & Sedvall, G. Neurosci. Lett. 136, 79–82 (1992).